Figure S3: Performance of novel multi-target stool DNA panel at fixed 90% specificity in the marker selection study; (A) Colorectal cancer (CRC) by stage and (B) advanced precancerous lesion (APL) by type; HGD, high-grade dysplasia; SSL, sessile serrated lesion
No takes yet. Share an insight, caveat, or question.
Gagrat et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: